Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Maguire

Showing results (31-40 of 373) with videos related to

Pageof 38
Sort By:
The New England Journal of Medicine|August 1, 2015
Targeting the Effect of VEGF in Diabetic Macular EdemaDaniel F Martin, Maureen G Maguire
The New England Journal of Medicine|August 21, 2018
n-3 Fatty Acid Supplementation and Dry Eye DiseaseMaureen G Maguire, Penny A Asbell,
The Mental Health Clinician|May 2, 2024
Opioid-positive urine drug screen during treatment with oral naltrexone and the clinical implicationsElena R Beauregard, Elizabeth G Maguire
The New England Journal of Medicine|February 19, 2015
Treatment choice for diabetic macular edemaDaniel F Martin, Maureen G Maguire
Archives of Ophthalmology (Chicago, Ill. : 1960)|February 15, 2001
It is not time to abandon radiotherapy for neovascular age-related macular degenerationS L Fine, M G Maguire
The Ocular Surface|August 16, 2019
Why DREAM should make you think twice about recommending Omega-3 supplementsPenny A Asbell, Maureen G Maguire,
Retina (Philadelphia, Pa.)|January 1, 1989
Reproducibility of refraction and visual acuity measurement under a standard protocol. The Macular Photocoagulation Study GroupD W Blackhurst, M G Maguire
JAMA Ophthalmology|June 9, 2022
Another Disappointment for ω-3 Fatty Acid and Dry Eye DiseasePenny A Asbell, Maureen G Maguire
International Journal for Parasitology|February 1, 1979
Ultrastructure of the vitelline follicles of Gorgoderina vitelliloba (Trematoda: Gorgoderidae)S W Irwin, J G Maguire
JAMA Ophthalmology|April 7, 2022
Phase 4 Studies on Phosphodiesterase 5 InhibitorsBrian L VanderBeek, Maureen G Maguire
Pageof 38

Showing results (31-40 of 373) with videos related to

Sort By:
Pageof 38
The New England Journal of Medicine|August 1, 2015
Targeting the Effect of VEGF in Diabetic Macular EdemaDaniel F Martin, Maureen G Maguire
The New England Journal of Medicine|August 21, 2018
n-3 Fatty Acid Supplementation and Dry Eye DiseaseMaureen G Maguire, Penny A Asbell,
The Mental Health Clinician|May 2, 2024
Opioid-positive urine drug screen during treatment with oral naltrexone and the clinical implicationsElena R Beauregard, Elizabeth G Maguire
The New England Journal of Medicine|February 19, 2015
Treatment choice for diabetic macular edemaDaniel F Martin, Maureen G Maguire
Archives of Ophthalmology (Chicago, Ill. : 1960)|February 15, 2001
It is not time to abandon radiotherapy for neovascular age-related macular degenerationS L Fine, M G Maguire
The Ocular Surface|August 16, 2019
Why DREAM should make you think twice about recommending Omega-3 supplementsPenny A Asbell, Maureen G Maguire,
Retina (Philadelphia, Pa.)|January 1, 1989
Reproducibility of refraction and visual acuity measurement under a standard protocol. The Macular Photocoagulation Study GroupD W Blackhurst, M G Maguire
JAMA Ophthalmology|June 9, 2022
Another Disappointment for ω-3 Fatty Acid and Dry Eye DiseasePenny A Asbell, Maureen G Maguire
International Journal for Parasitology|February 1, 1979
Ultrastructure of the vitelline follicles of Gorgoderina vitelliloba (Trematoda: Gorgoderidae)S W Irwin, J G Maguire
JAMA Ophthalmology|April 7, 2022
Phase 4 Studies on Phosphodiesterase 5 InhibitorsBrian L VanderBeek, Maureen G Maguire
Pageof 38